Eclipse gets conditional $20 million equity boost:
This article was originally published in Clinica
Eclipse Surgical Technologies has gained a commitment from Acqua Wellington North American Equities for equity financing of up to $20 million, based on its share price performance over the next 15 months. The money will provide working capital for the Sunnyvale, California company as it moves towards an anticipated FDA approval for its transmyocardial revascularisation laser therapy. Acqua Wellington invests in small and mid-cap public companies focusing on life sciences and technology.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.